Dr. Baum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
222 Station Plz N
Ste 618
Mineola, NY 11501Phone+1 317-523-0841
Summary
- Dr. Jordan Baum is a pathologist in New York and is affiliated with NYU Long Island. She received her medical degree from Indiana University School of Medicine and has been in practice since 2019 after completing AP/CP residency and two fellowships at Weill Cornell. She specializes in molecular genetics, anatomic pathology, clinical pathology, and surgical pathology with a focused interest in breast pathology. She has more than 10 publications and over 50 citings.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2013 - 2017
- Indiana University School of MedicineClass of 2013
Certifications & Licensure
- NY State Medical License 2016 - 2026
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definit...Yungtai Lo, Susan C Lester, Ian O Ellis, Sonali Lanjewar, Javier Laurini
Archives of Pathology & Laboratory Medicine. 2024-10-01 - 7 citationsApocrine Variant of Pleomorphic Lobular Carcinoma In Situ: Further Clinical, Histopathologic, Immunohistochemical, and Molecular Characterization of an Emerging Entity.Elaine Zhong, James P. Solomon, Esther Cheng, Jordan E. Baum, Wei Song
The American Journal of Surgical Pathology. 2020-08-01 - Breast core needle biopsy may be sole determinant of pathologic tumor (pT) category and the only specimen available for ancillary testing.William S. Towne, Jordan E. Baum, Paula S. Ginter
The Breast Journal. 2020-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: